CDEK
← All trials

NCT02235909

Phase 3Interventional

Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 1, 2014
Primary completion
Feb 1, 2018
Completion date
Aug 1, 2018
First posted
—
Last posted
—
Enrollment
260
Arms / groups
4 / —
Source
AACT · pre-existing

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.